MGM Resorts Stock Drops 9% After People Inc. Withdraws Takeover Offer
MGM Resorts shares fell 9% after People Inc. withdrew its offer, removing takeover-premium expectations and raising caution for merger-arbitrage trade…
Eli Lilly Stock Nears $1,200 After Weekly Insulin Approval and $3.25 Billion InnoCare Deal
Eli Lilly shares reached $1,191.92 after FDA approval of weekly insulin Onswik and a $3.25 billion InnoCare agreement broadened its growth narrative.
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
Elmet Group's Strategic Move: Acquiring Stake in Tungsten Supply Amid Rising Demand
Elmet Group's $125 million acquisition signals a pivotal shift in the tungsten supply landscape for the U.S. market.
aTyr Pharma's FDA Protocol Alignment Sparks Pre-Market Surge: What Investors Need to Know
aTyr Pharma's stock jumped 9.8% in pre-market trading after FDA trial protocol alignment, highlighting a key milestone f…
Eli Lilly's Onswik Approval: A Game Changer for Diabetes Management and Investment Potential
Eli Lilly's recent FDA approval of Onswik represents a significant advancement in diabetes treatment and investment pote…
Alkami Technology Faces Selloff: Implications of Ending Its Strategic Review
Alkami Technology's decision to remain independent leads to a significant stock selloff, impacting fintech valuations.
GRAIL Inc. Surges 34%: What Investors Need to Know About the Galleri Test and FDA Approval Odds
GRAIL Inc. stock surged 34% following FDA briefing insights on its Galleri test. Here's what investors should know.
IonQ's Quantum Leap: Analyzing the Impact of the First Real-Time Error Decoder
IonQ's breakthrough in quantum computing with its real-time error decoder could reshape the tech landscape.
Qualcomm's Strategic Acquisition: Analyzing the Impact of PickNik Purchase
Qualcomm's acquisition of PickNik marks a pivotal shift into robotics software, reshaping its market strategy and reflec…
Viking Therapeutics Soars 35%: What This Means for the Biopharma Sector
Viking Therapeutics shares surged 35.67% following positive clinical trial results for its weight loss drug, raising que…
IonQ's Quantum Leap: The Impact of Real-Time Error Decoder on Tech Stocks
IonQ's breakthrough in quantum computing could reshape investor sentiment and the competitive landscape.